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Severe late toxicity involving the lungs, kidneys and thyroid was 
relatively low. The risk of second cancers was acceptable. Our 
study indicates that this approach is both safe and effective. 
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Purpose: The use of 3D printing for medical use is well 
established and has been utilized in clinical practices ranging 
from surgical planning to individualized medical implants. Three-
dimensional printing has been implemented at our institution to 
create customized treatment accessories such as shielding and 
immobilization. In order to use 3D printing, the topography of 
the patient must first be acquired. We have previously achieved 
this using resource intensive methods such as a plaster mould or 
a CT scan. Recently, 3D scanners have been developed which are 
low cost (~$500), and can quickly acquire both the topographical 
and texture information of a patient. These scanners use 
methods such as structured light in order to construct accurate 
3D models in minutes. We have characterized a structured light 
3D scanner (3D Systems Sense), and have designed and built a 
scanning gantry in order to assess the clinical viability of this 
technology. 
Methods and Materials: The gantry consists of a circular hoop 
formed from square aluminum tubing, with a diameter of 126.5 
cm. The optical scanner is mounted to an arm that can be moved 
isocentrically along the circumference of the hoop. The scanner-
to-surface distance is adjustable to accommodate differently 
sized regions of the body. The gantry can tilt with respect to the 
patient table, allowing for acquisition of topography from 
virtually any direction. The gantry was built in-house with a total 
cost of about $500. 
An anthropomorphic head phantom was used to quantify the 
accuracy of the gantry-mounted 3D scanner. Meshes acquired 
using the 3D scanner were compared to a mesh generated from 
a high resolution CT scan, which was taken to be the gold 
standard. Optimal scan settings were identified and final 
assessment of the accuracy of the scanner was quantified using 
the Hausdorff distance between the two meshes. 
Results: The in-house gantry enabled quick and easy acquisition 
of patient topographical information with a low cost 3D scanner. 
Acquisition was much easier than using the scanner free-hand. 
The mean Hausdorff distance was typically found to be less than 
0.5 mm, with maximum errors in the range of 1-2 mm. This was 
deemed to be clinically acceptable and the scanner has been 
used to design treatment accessories for several skin cancer 
patients. 
Conclusions: Through a collaborative and innovative approach, 
an optical scanner gantry has been developed which can quickly, 
easily and accurately acquire topographical information. This 
information can then be used to design customized treatment 
accessories for many different treatment sites and modalities, 
including bolus and immobilization for both photon and electron 
treatments and shielding for orthovoltage treatments. The 
gantry is very lightweight and easy to store. 
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Purpose: To evaluate the use of VMAT planning techniques for 
para-aortic and ipsilateral pelvic irradiation in seminoma 
patients, driven by standard kidney contours and automatically 
generated concentric rings about the PTV. 
Material and Methods: Ten seminoma patients with small 
volume retroperitoneal nodes (< 5 cm) were randomly selected. 
CTV2 included the gross tumour plus a 5 mm margin, and CTV1 
was contoured based on an expansion of blood vessels. PTV was 
defined by addition of 5 mm margin around the corresponding 
CTV, with PTV1 extending from 2 cm below the top of kidney to 
the top of femoral head, and modified to exclude both kidneys. 
The prescription dose (in 20 fractions) was 25 and 35 Gy for PTV1 
and PTV2 respectively. Abdominal and pelvic organs at risk (OAR) 
were contoured. For each patient, a conformal (AP-PA, 18 MV) 
and VMAT (two 360-degree coplanar arcs, six MV, 15-degree 
collimator twist) plans were created. Dose constraints for the 
VMAT optimization were: Rt and Lt Kidney (D50% <350 cGy, max 
EUD < 350 cGy); RingPTV+2 cm (max dose = PTVmin), Normal 
tissue 4 cm beyond PTV (max dose < 1000 cGy, D50% < 150 cGy, 
D20% < 500 cGy). No other structures were included in the 
optimization. The maximum (D2%), mean (D50%) and minimum 
dose (D98%) for PTVs and OAR were obtained and compared 
between plans. 
Results: There was no difference in the coverage of PTV2, while 
VMAT provided better PTV1 coverage: mean D98% was 24.2 Gy 
+/- 0.16 versus 23.9 Gy +/- 0.25 (p = 0.05). Use of VMAT reduced 
the volume of normal tissue receiving 95% of the prescribed dose 
from 11% to 2%, compared to the conformal AP-PA plans (p = 
0.005). Kidney D2% was reduced by 6Gy with VMAT (p = 0.03), 
while the kidney D50% was 1.3 Gy higher (p = 0.01). There was 
no significant difference in D2% or D50% for either heart or 
pancreas. VMAT reduced spinal cord dose: D2% (28.2 Gy +/- 2.2 
versus 32.2 Gy +/-4.4, p = 0.02) and D50% (12.6 Gy +/- 8.7 versus 
19.8 Gy +/- 7.4, p = 0.01), and reduced the D2% for bone marrow 
(p = 0.01), large bowel (p = 0.05) and stomach (p = 0.05) but not 
for bladder or liver. Conversely, the conformal APPA resulted in 
lower D50% to bone marrow (p = 0.01), large bowel (p = 0.05), 
stomach (p = 0.01), bladder (p = 0.05) and liver (p = 0.05). 
Conclusions: It is possible to generate organ-sparing VMAT plans 
with only the kidneys and automatically generated concentric 
PTV rings included in the optimization process. Use of VMAT for 
para-aortic/pelvic irradiation improves the conformality of the 
isodoses to the PTV and reduces the maximum dose to the 
surrounding OAR, but at the cost of an increase in the low dose 
region. 
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Purpose: Treatment of non-melanoma skin cancers of the face 
using ortho-voltage radiotherapy may require lead shielding to 
protect vulnerable organs at risk (OAR). As the human face has 
many complex and intricate contours, creating a lead shield can 
be difficult. The process can include creating a plaster mould of 
a patient’s face to create the shield. It can be difficult or 
impossible for a patient who is claustrophobic or medically 
unable to lie flat to have a shield made by this technique. Other 
methods have their own shortcomings. We aimed to address 
some of these issues using an optical scanner and 3D printer 
technology. 
Methods and Materials: The clinicians identified three patients 
with skin cancer involving the nose who required treatment with 
low energy photons and would benefit from lead shielding. 
Marking was made on these patients to define the field. Optical 
images of these patients were acquired using a consumer-grade 
optical scanner (3D Systems, Sense). A 3D model of each patient 
was processed with mesh editing software (Autodesk, MeshMixer 
v2.9) before being exported as an STL file to software controlling 
the printer (Repetier-Host). A positive model of each face was 
printed using polylactic acid on a consumer-Grade 3D printer 
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(MakerGear, M2). The infill settings were chosen so that the 
resulting models would be very rigid and durable. Using a 
hammer, a 3 mm thick, layer of lead was bent to fit the contours 
of the model. A hole was then cut out to define the field, and 
the lead was clear coated. 
Results: The lead shields created were remarkably accurate and 
fit the contours of the patients. The hole cut to define the field 
exposed only a minimally sized site to be irradiated. The rest of 
the face, including vulnerable OAR, were protected. The length 
of time during which the patient’s presence was required was 
minimal, as was the time spent by staff to create the mask. 
Conclusions: Using this technology to create lead shielding for 
radiotherapy of skin cancer of the face is an innovative and 
exciting approach. This could save valuable clinic time and add 
patient convenience. Some traditional methods require an extra 
appointment to create a facial mould. The optical scan can be 
obtained on the day of the clinical visit with no subsequent visit 
required until first treatment. If there are issues generating the 
lead shield the patient doesn’t need to come in for another visit; 
the saved 3D optical image can be used to generate another lead 
shield. The cost of manufacture is also low; centres, such as 
those in the developing world that may not have the 
infrastructure to treat skin cancer with electrons could use this 
method to safely deliver ortho-voltage treatments. A significant 
number of patients suffer from claustrophobia, and this could be 
addressed by using this technology. 
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Purpose: Medulloblastoma most frequently occurs in the 
pediatric age group and craniospinal irradiation (CSI) is a 
standard component of management. CSI is technically 
challenging due to the possibility of multiple junctions, each 
with shifts, required to treat the craniospinal axis; more so if the 
patient requires anesthesia. Several techniques are described in 
the literature addressing how to avoid junctions however the use 
of those techniques for all comers is an issue. The aim of this 
work is to develop a simple image guided IMRT technique for CSI 
on the Varian Eclipse platform, deliverable on Varian linacs, with 
intrafraction modulated junctions while reducing dose to normal 
structures. 
Methods and Materials: Using Varian treatment planning 
software and linacs the proposed technique sets one table height 
and one lateral position for all plans as well as allows for imaging 
of each of the two or three isocentres to verify patient set up. 
Further, the spinal axis is treated using three IMRT fields which 
allows for increased dose homogeneity while limiting the amount 
of patient volume being treated to a low dose, while the brain is 
treated using IMRT with a POP arrangement. 
Results: Using the proposed technique we re-planned patients 
previously treated prone with extended source to skin distance 
(SSD), with field matching on skin. All planning parameters were 
compared. The proposed technique reduced plan maximum dose 
on the order of 10% while also reducing the mean dose to the 
optic structures and heart. The mean dose to the kidneys was 
comparable between techniques while the mean dose to the lung 
was slightly higher with the new technique while the maximum 
dose to the lungs was lower with the new technique. Using the 
new technique, two further patients were scanned and planned 
in supine position. The total PTV length for these patients was 
74 and 56 cm respectively. Delivery of general anesthesia and 
monitoring was easy. 
Conclusions: The proposed technique is a simple to deliver, 
image guided IMRT technique using Varian equipment with 
intrafraction modulated junctions. This technique allows for easy 
set up verification and less dose to normal structures. 
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Purpose: Respiratory gating (RG) has been postulated as a 
method of reducing the irradiation of normal lung during SABR. 
RG refers to tumour treatment only during a specific phase or 
amplitude of the breathing cycle, in distinction to non-gated 
(NG) free-breathing delivery. The inability to visualize the 
tumour during RG with most systems has led to the hypothesis 
that geometric misses could occur, leading to a lower rate of 
local control (LC). The goal of this study was to assess oncological 
outcomes in patients receiving RG versus NG treatments.  
Methods and Materials: Outcomes for patients treated with 
SABR in 2010-15 for either primary non-small cell lung cancer 
(NSCLC) or metastatic disease were reviewed. Patients received 
a risk-adapted approach, using 3, 5, or 8 fractions (all with BED 
> 100 Gy10) depending on tumour size and location. Tumour 
motion was assessed using 4D-CT. RG was generally used when 
tumour motion was > 7 mm, with RG treatment delivered during 
end-expiration. Outcomes for RG and NG groups were estimated 
using Kaplan-Meier analyses, with propensity matching (in a 1:1 
ratio with a caliper width of 0.20) to control for baseline 
differences. 
Results: One hundred and nine patients were treated for primary 
NSCLC and 39 for oligometastatic cancers. Median follow up was 
17 months. Median age was 75 (range 42-94), most were male 
(56%), median FEV1 was 71% predicted (range 23-127% 
predicted), and median age-adjusted Charlson score was 7 
(range 3-13). Most patients (85%) had one lesion treated. In the 
whole cohort, there were eight local failures (three-year local 
control rate 88%), and nine regional failures (three-year regional 
failure rate 85%). Tumour location was the strongest predictor of 
use of RG (59% for lower lobe tumours versus 15% for others). 
Patients who received RG were also more likely to be older, with 
more target lesions, a higher Charlson score, and larger targets 
(all p < 0.05); these differences were no longer significant after 
matching. Comparing RG versus NG outcomes in matched 
patients (n = 52 in each group), there were no differences in LC 
(p = 0.23) associated with delivery technique. 
Conclusions: The use of RG does not appear to adversely affect 
local control rates. Further research is needed to determine if 
dosimetric benefits of RG lead to clinically improved outcomes.  
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Purpose: Total body irradiation (TBI) is given as part of a 
conditioning regime for stem cell transplant. Methods of delivery 
are often labour intensive, not comfortable for the patient, and 
provide limited capabilities for shielding critical structures 
without compromising treatment goals of irradiating the whole 
body, including skin, to a uniform ± 10% of the prescription dose. 
For example, our previous technique involved full patient bolus 
packing at extended SSD using lateral treatment fields. The 
patient’s arms were used to provide attenuation for lungs, and 
there was no ability to shield the gonads without compromising 
the dose to the pelvic bones. 
Methods and Materials: At the Tom Baker Cancer Centre (TBCC), 
we have implemented a new total body irradiation method that 
delivers a uniform dose using volumetric modulated arc therapy 
(VMAT) through gantry speed and MLC motion optimization. The 
MLC motion is limited to shielding for the lungs and reducing hot 
spots, and consequently, plans are not highly modulated. This 
allows us to streamline the treatment planning and quality 
